Rhythm Pharmaceuticals Announces Topline Results from Phase 3 EMANATE Trial

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/12/2026

1. ADBE
2. SPCX
3. USO
4. SPY
5. RH
6. NVDA
7. RKLB
8. CRM
9. MSFT
10. DOL:CN

Go back to Rhythm Pharmaceuticals Announces Topline Results from Phase 3 EMANATE Trial
(NASDAQ: RYTM) Delayed: 88.38 +0.72 (0.82%)
Previous Close $87.66    52 Week High $ 
Open $87.65    52 Week Low $ 
Day High $90.16    P/E N/A 
Day Low $87.65    EPS $ 
Volume 552,755